FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1450-1452 April 1, 2004 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Danesh, J. PubMed Citation

In this issue of the Journal, Danesh and colleagues report that elevated levels of C-reactive protein (CRP) are associated with only a moderate increase in the risk of coronary heart disease (CHD).¹ Although these findings are in line with those of other large studies, the independent relative risk associated with increased CRP levels is considerably less than in some earlier reports. Using a multivariate analysis, the authors found that the predictive value of CRP measurement adds relatively little to that provided by assessments of traditional risk factors. In contrast, a smaller study suggested that the CRP level could be more . . . [Full Text of this Article]

Source Information

From the Division of Molecular Medicine, Department of Medicine, Columbia University Medical Center, New York.

Related Letters:

C-Reactive Protein and Coronary Heart Disease
Glynn R. J., Cook N. R., Libby P., Willerson J. T., Braunwald E., Foody J. M., Gotto A. M., Wenger N., Ridker P. M., Koenig W., Fuster V., Danesh J., Pepys M., Gudnason V.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:295-298, Jul 15, 2004. Correspondence

This article has been cited by other articles:

• Blumenthal, J. A, Sherwood, A., Rogers, S. D., Babyak, M. A., Murali Doraiswamy, P., Watkins, L., Hoffman, B. M., O'Connell, C., Johnson, J. J., Patidar, S. M., Waugh, R., Hinderliter, A. (2007). Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study rationale, design, and methodological issues. Clin Trials 4: 548-559 [Abstract]  
• Sinning, J.-M., Bickel, C., Messow, C.-M., Schnabel, R., Lubos, E., Rupprecht, H. J., Espinola-Klein, C., Lackner, K. J., Tiret, L., Munzel, T., Blankenberg, S., for the Athero Gene Investigators, (2006). Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study. Eur Heart J 27: 2962-2968 [Abstract] [Full Text]  
• Vermeire, S, Van Assche, G, Rutgeerts, P (2006). Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55: 426-431 [Full Text]  
• Miller, M., Zhan, M., Havas, S. (2005). High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors: The Third National Health and Nutrition Examination Survey. Arch Intern Med 165: 2063-2068 [Abstract] [Full Text]  
• Richards, A. M., Frampton, C. M. (2005). N-Terminal-Pro-B-Type Natriuretic Peptide: Universal Marker of Cardiovascular Risk?. Circulation 112: 9-11 [Full Text]  
• Campbell, D. J., Woodward, M., Chalmers, J. P., Colman, S. A., Jenkins, A. J., Kemp, B. E., Neal, B. C., Patel, A., MacMahon, S. W. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation 112: 110-116 [Abstract] [Full Text]  
• Glynn, R. J., Cook, N. R., Libby, P., Willerson, J. T., Braunwald, E., Foody, J. M., Gotto, A. M., Wenger, N., Ridker, P. M., Koenig, W., Fuster, V., Danesh, J., Pepys, M., Gudnason, V. (2004). C-Reactive Protein and Coronary Heart Disease. NEJM 351: 295-298 [Full Text]